The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.

The global platelet function test market is poised for robust growth over the next decade, fueled by innovations in diagnostic technologies and increasing demand for personalized, preventive ...

Using platelet function testing to determine the optimal time for coronary artery bypass graft (CABG) surgery can shorten the waiting time before bypass in clopidogrel-treated patients without ...

Clopidogrel is often the antiplatelet agent of choice for patients with ACS or those receiving a stent because, as a generic, it is inexpensive and, as a drug that has been around for a long time, it ...

LOS ANGELES, CA—In patients with acute coronary syndromes (ACS) treated with prasugrel, the incidence of high on-treatment platelet reactivity depends on the type of platelet function test used, ...

SAN FRANCISCO, CA — Physicians are far more likely to order a VerifyNow (Accumetrics) platelet-function test for their patients with acute MI if the point-of-care assay is offered to them for free, ...

LOS ANGELES — Patients with intracranial aneurysm who respond poorly to the antiplatelet drug clopidogrel when treated with flow diversion using the Pipeline embolization device (Medtronic) have ...

An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...

Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate ...

While thrombocytopenia and bleeding are events that often occur together in neonates, this may not signify cause and effect. In fact, one study reported that 91% of neonates with low platelet counts ...

A clinical trial of patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) and stable angina showed that a strategy of rapid genotyping followed by selective ...